330 related articles for article (PubMed ID: 11017791)
41. Detection of MMTV-like LTR and LTR-env gene sequences in human breast cancer.
Wang Y; Pelisson I; Melana SM; Holland JF; Pogo BG
Int J Oncol; 2001 May; 18(5):1041-4. PubMed ID: 11295054
[TBL] [Abstract][Full Text] [Related]
42. Antisense downregulation of a mouse mammary tumor virus activated protooncogene in mouse mammary tumor cells reverses the malignant phenotype.
Li YX; Papkoff J; Sarkar NH
Virology; 1999 Mar; 255(1):138-49. PubMed ID: 10049829
[TBL] [Abstract][Full Text] [Related]
43. Sequence similarity between the long terminal repeat coding regions of mammary-tumorigenic BALB/cV and renal-tumorigenic C3H-K strains of mouse mammary tumor virus.
Kang JJ; Schwegel T; Knepper JE
Virology; 1993 Sep; 196(1):303-8. PubMed ID: 8395120
[TBL] [Abstract][Full Text] [Related]
44. CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription.
Zhu Q; Dudley JP
J Virol; 2002 Mar; 76(5):2168-79. PubMed ID: 11836394
[TBL] [Abstract][Full Text] [Related]
45. Glucocorticoids stimulate growth of human papillomavirus type 16 (HPV16)-immortalized human keratinocytes and support HPV16-mediated immortalization without affecting the levels of HPV16 E6/E7 mRNA.
Khan MA; Canhoto AJ; Housley PR; Creek KE; Pirisi L
Exp Cell Res; 1997 Oct; 236(1):304-10. PubMed ID: 9344611
[TBL] [Abstract][Full Text] [Related]
46. Mouse mammary tumor virus encodes a self-regulatory RNA export protein and is a complex retrovirus.
Mertz JA; Simper MS; Lozano MM; Payne SM; Dudley JP
J Virol; 2005 Dec; 79(23):14737-47. PubMed ID: 16282474
[TBL] [Abstract][Full Text] [Related]
47. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.
Schirrmacher V; Beutner U; Bucur M; Umansky V; Rocha M; von Hoegen P
J Immunol; 1998 Jul; 161(2):563-70. PubMed ID: 9670928
[TBL] [Abstract][Full Text] [Related]
48. Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.
Overhauser J; Fan H
J Virol; 1985 Apr; 54(1):133-44. PubMed ID: 2983110
[TBL] [Abstract][Full Text] [Related]
49. Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: a reappraisal of the enhancer insertion model.
Clausse N; Baines D; Moore R; Brookes S; Dickson C; Peters G
Virology; 1993 May; 194(1):157-65. PubMed ID: 8386870
[TBL] [Abstract][Full Text] [Related]
50. Transforming growth factor-beta represses transcription of the mouse mammary tumour virus DNA in cultured mouse mammary cells.
Cato AC; Mink S; Nierlich B; Ponta H; Schaap D; Schuuring E; Sonnenberg A
Oncogene; 1990 Jan; 5(1):103-10. PubMed ID: 2157176
[TBL] [Abstract][Full Text] [Related]
51. [Requirement of class II and membrane proximal region of mouse mammary tumor virus superantigen (Mtv SAG) in Mtv7 SAG presentation].
Okamoto M; Kimura S; Katagiri M
Hokkaido Igaku Zasshi; 1998 May; 73(3):205-14. PubMed ID: 9719947
[TBL] [Abstract][Full Text] [Related]
52. In vitro analysis of transcriptional repression of the mouse mammary tumor virus promoter.
Kang CJ; Peterson DO
Biochem Biophys Res Commun; 2001 Sep; 287(2):402-10. PubMed ID: 11554742
[TBL] [Abstract][Full Text] [Related]
53. A small region of the mouse mammary tumor virus long terminal repeat confers glucocorticoid hormone regulation on a linked heterologous gene.
Majors J; Varmus HE
Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5866-70. PubMed ID: 6310597
[TBL] [Abstract][Full Text] [Related]
54. Superantigen expression is driven by both mouse mammary tumor virus long terminal repeat-associated promoters in transgenic mice.
Salmons B; Miethke T; Wintersperger S; Müller M; Brem G; Günzburg WH
J Virol; 2000 Mar; 74(6):2900-2. PubMed ID: 10684308
[TBL] [Abstract][Full Text] [Related]
55. Promoter complex in the central part of the mouse mammary tumor virus long terminal repeat.
Rouault F; Nejad Asl SB; Rungaldier S; Fuchs E; Salmons B; Günzburg WH
J Virol; 2007 Nov; 81(22):12572-81. PubMed ID: 17686873
[TBL] [Abstract][Full Text] [Related]
56. Specific deactivation of the mouse mammary tumor virus long terminal repeat promoter upon continuous hormone treatment.
Boronat S; Richard-Foy H; Piña B
J Biol Chem; 1997 Aug; 272(35):21803-10. PubMed ID: 9268310
[TBL] [Abstract][Full Text] [Related]
57. Green tea polyphenols as potent enhancers of glucocorticoid-induced mouse mammary tumor virus gene expression.
Abe I; Umehara K; Morita R; Nemoto K; Degawa M; Noguchi H
Biochem Biophys Res Commun; 2001 Feb; 281(1):122-5. PubMed ID: 11178969
[TBL] [Abstract][Full Text] [Related]
58. Comparative analysis of inducible expression systems in transient transfection studies.
Meyer-Ficca ML; Meyer RG; Kaiser H; Brack AR; Kandolf R; Küpper JH
Anal Biochem; 2004 Nov; 334(1):9-19. PubMed ID: 15464949
[TBL] [Abstract][Full Text] [Related]
59. The mouse mammary tumor virus transcription enhancers for hematopoietic progenitor and mammary gland cells share functional elements.
Reuss FU; Coffin JM
J Virol; 2000 Sep; 74(17):8183-7. PubMed ID: 10933730
[TBL] [Abstract][Full Text] [Related]
60. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H
J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
